Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.22.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 961 $ 672,304 $ (570,704) $ (10) $ 102,551
Beginning balance, shares at Dec. 31, 2020 96,131,678        
Stock-based compensation expense 1,950 1,950
Issuance of common stock under open market sale agreement $ 16 5,195 5,211
Issuance of common stock under open market sale agreement, shares 1,578,324        
Issuance of common stock in connection with the  exercise of stock options $ 5 662 667
Issuance of common stock in connection with the exercise of stock options, shares 488,204        
Net loss (16,002) (16,002)
Other comprehensive income 13 13
Issuance of common stock in connection with restricted share awards, net of cancellations $ 8 (8)
Issuance of common stock in connection with restricted share awards, net of cancellations, shares 840,727        
Ending balance, value at Mar. 31, 2021 $ 990 680,103 (586,706) 3 94,390
Ending balance, shares at Mar. 31, 2021 99,038,933        
Beginning balance, value at Dec. 31, 2021 $ 1,472 705,570 (655,640) (27) 51,375
Beginning balance, shares at Dec. 31, 2021 147,205,422        
Stock-based compensation expense 862 862
Issuance of common stock in connection with restricted share awards, net of cancellations $ (1) 1
Cancellations, net , shares (125,523)        
Net loss (20,791) (20,791)
Other comprehensive income (3) (3)
Ending balance, value at Mar. 31, 2022 $ 1,471 $ 706,433 $ (676,431) $ (30) $ 31,443
Ending balance, shares at Mar. 31, 2022 147,079,899